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Purpose: The currently available drug repertoire against lymphatic filariasis, a major health 
hazard in the developing world, is inadequate and is fraught with serious limitations. Thus, the 
development of an effective antifilarial strategy has become a global research thrust mandated 
by the World Health Organization. Nanoparticles of silver endowed with antibacterial potency 
are known to induce apoptosis in eukaryotic cells. The present study was designed to investi-
gate the possible microfilaricidal efficacy of silver nanoparticles and to establish the validity 
of apoptotic rationale in antifilarial drug designing.
Methods: This report analyzed the effect of nanoparticles of silver as well as gold (size range: 
10–15 nm) on the microfilariae of Brugia malayi obtained from the lavage of peritoneal cavities 
of infected jirds (Meriones unguiculatus). The study included a microfilarial motility assay, 
a trypan blue exclusion test, a poly(adenosine diphosphate-ribose) polymerase activity study, 
ethidium bromide/acridine orange differential staining, and transmission, as well as scanning 
electron microscopic evaluation of ultrastructural changes in microfilariae.
Results: The study demonstrates that nanoparticles of silver, but not of gold, elicited signifi-
cant loss in microfilarial motility. Differential staining of parasites with ethidium bromide 
and acridine orange, poly(adenosine diphosphate-ribose) polymerase activity in microfilarial 
lysate, and electron microscopic findings underscored apoptotic death of parasites attribut-
able to nanosilver. In a trypan blue exclusion test, the 50% lethal dose of nanosilver was 
measured to be 101.2 µM, which was higher than the recorded complete inhibitory concen-
tration value (50.6 µM), thus supporting nanosilver as a potential drug candidate against 
lymphatic filariasis.
Conclusion: The present report provides the first ever conclusive proof in support of apoptosis 
as a novel stratagem in antifilarial drug designing and nanoscale silver as a valid lead in research 
on antifilarial therapeutics. The main embargo about the current drug diethylcarbamazine citrate 
is its empirical use without rationale. Effective microfilaricidal activity of nanosilver at rela-
tively low concentrations as reported in this study, with evidence of the induction of apoptosis 
in microfilariae, projects nanosilver as a potential drug adjuvant against lymphatic filariasis. 
The much higher 50% lethal dose value of nanosilver compared to the complete inhibitory 
concentration value reported in this study argues in favor of a safe therapeutic window of this 
agent in its antifilarial efficacy.
Keywords: silver nanoparticles, apoptosis, lymphatic filariasis, microfilaricidal agent, parasitic 
diseases
Introduction
Human lymphatic filariasis is a major vector-borne disease in countries of tropical 
and subtropical regions caused by the nematode parasites Wuchereria bancrofti and 
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Brugia malayi. The adult forms of the parasites harbor in 
host lymphatic tissue, whereas the microfilarial forms (Mf) 
circulate in the blood as a reproductive product. The latter are 
transmitted to the mosquito vector where the larval (infective) 
stage is generated. Passage of infective larvae into humans 
and subsequent development into adult worms complete the 
life cycle. The disease has varied presentations depending 
on the host immune status. Despite accelerated research 
to develop an effective therapeutic regimen against the 
disease, the antifilarial drug inventory still remains limited to 
diethylcarbamazine citrate (DEC).1 Since last century, DEC 
has been almost the sole antifilarial drug, and its inherent 
disadvantages such as unwanted side effects, lack of patient 
compliance, and poor macrofilaricidal effectiveness2 have 
warranted research on new antifilarial drug development. 
The World Health Organization has placed special emphasis 
on the development of novel drugs against human lymphatic 
filariasis, realizing the severe socioeconomic and emotional 
burden of this disease on developing nations.3 An estimated 
populace of approximately 120 million clinical cases of 
lymphatic filariasis, with another 751 million people living 
in endemic areas, are bare statistics of this harsh fact.4 
According to the Indian Council of Medical Research, more 
than 550 million people are exposed to filarial infection in 
India, which is estimated to be 40% of the total global burden 
of the disease.5
The natural response of the host to the microbial pathogen 
is inflammation.6 Oxidative stress is a major contributing 
factor to innate immunity,7 and hence generation of 
a pro-oxidant state provides a premise for antifilarial 
drug development. The authors have earlier reported 
potential antifilarial properties of traditional therapeutic 
herbal extracts composed of polyphenolics8 and synthetic 
inhibitors of dihydrofolate reductase.9 Nanoparticles of 
silver (AgNPs) endowed with antibacterial potency10,11 
induced p53 expression and apoptosis in eukaryotic 
cells.12,13 Strikingly, free radical generation has been 
implicated in the apoptosis induced by AgNPs.14–16 DEC 
was also shown to induce microfilarial apoptosis.17 DEC 
acts in an innate response-mimetic manner by recruitment of 
macrophages and by invoking proinflammatory status.6 The 
importance of apoptosis in the host–parasite relationship 
is not itself a unique concept;18 however, it has never been 
explored as an antifilarial therapeutic strategy. With this 
perspective, the present study was designed to investigate 
the possible microfilaricidal efficacy of AgNPs and to 
establish the validity of apoptotic rationale in antifilarial 
drug designing.
Materials and methods
Synthesis and characterization  
of biocompatible nanoparticles
AgNPs were synthesized following the procedure described 
in earlier reports.11,19,20 In short, 0.017 g silver nitrate was 
dissolved in deionized water along with sodium hydroxide 
(0.01 M) and liquid ammonia (2%) to form a 0.01 M solution of 
stable soluble complex of silver ions. D-glucose and hydrazine 
(each at 0.01 M concentration) were added to the solution of 
silver ions to ensure its complete reduction at a final concentra-
tion of 0.005 M. The pH of the solution was adjusted to 7.4 with 
citric acid. The final solutions were carefully stored in glass 
vials at 4°C for further characterization. The size, morphology, 
and distribution of AgNPs were characterized using a trans-
mission electron microscope (Tecnai 12; Philips, Eindhoven, 
the Netherlands) and an ultraviolet–visible spectrophotometer 
(GE Life Sciences, Uppsala, Sweden). Nanoparticles were 
found to be spherical in shape with average size of 10–15 nm 
(Figure 1). Before each experiment, the solution containing 
the nanoparticles was sonicated (Labsonic® 2000; B Braun 
Melsungen AG, Melsungen, Germany) for about 2 minutes and 
passed through filters of 0.2 µm pore size (Sartorius Stedim 
Biotech, Gottingen, Germany). Gold nanoparticles (AuNPs) 
(G1527; 10 nm diameter) were procured from Sigma-Aldrich 
Corporation (Bangalore, India).
Collection and preparation  
of B. malayi microfilariae
Microfilariae of B. malayi were obtained by lavage from the 
peritoneal cavities of infected jirds (Meriones unguiculatus). 
The Mf used for in vitro experiments were collected, washed 
with Roswell Park Memorial Institute (RPMI) 1640 medium 
supplemented with antibiotics (gentamicin 20 mg; penicillin 
100 mg; streptomycin 100 mg), 15 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid, organic acids (malic acid, 
α-ketoglutaric acid, D-succinic acid, and fumaric acid at 
concentrations of 670, 370, 60, and 55 mg/L, respectively) 
and sugars (sucrose and fructose at concentrations of 26.7 g/L 
and 0.4 g/L, respectively). The use of animals for the study 
was approved by the Institutional Animal Ethics Committee 
which follows the Committee for the Purpose of Control and 
Supervision of Experiments on Animals norms.
In vitro screening for antifilarial activity 
against B. malayi
In vitro screening for antifilarial activity against B. malayi 
was carried out as described earlier.8 Approximately 100 Mf 
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(in 100 µL RPMI) were introduced into each well of 24-well 
microculture plates. B. malayi microfilariae were screened for 
the antifilarial effect of AgNPs in vitro over a wide dose range 
(1–100 µM). Microfilariae were treated similarly with AuNPs 
of comparable sizes to rule out any nonspecific nanoparticle 
effect. As a positive control, staurosporine – a known inducer 
of apoptosis – was added to the microfilariae at 0.5 µM (elicits 
100% loss in motility), whereas Mf in RPMI medium, in the 
absence of any agent added, was used as a negative control 
(vehicle). The plates were incubated for 48 hours at 37°C 
in the presence of 5% carbon dioxide. Subsequently, the 
number of live and dead Mf in each well was counted under 
an inverted microscope (Nikon Corporation, Tokyo, Japan) 
and the percentage of motile Mf out of total Mf recruited per 
aliquot was calculated.
Determination of 50% lethal  
dose for nanosilver
Cytotoxicity of AgNPs was evaluated by a trypan blue 
dye exclusion assay. Peripheral blood mononuclear cells 
(1 × 105 cells/mL) were exposed to varying concentrations 
of AgNPs for 48 hours followed by incubation with trypan 
blue (0.2 mg/mL) for 1 minute. Cells were observed under 
a Nikon light microscope (Tokyo, Japan) and the viable cell 
ratio were calculated by counting the stained and unstained 
cells separately.21 Viable cells do not uptake trypan blue, 
whereas nonviable cells with porous membranes stain blue. 
The cytotoxicity of the nanoparticles was evaluated and the 
50% lethal dose was determined.
Poly(adenosine diphosphate-ribose) 
polymerase (PARP) activity assay
PARP activity in B. malayi microfilariae was determined 
using a commercial kit (R & D Systems Inc, Minneapolis, 
MD) according to the manufacturer’s instruction. Briefly, 
100 µL aliquots of suspension (containing about 100 Mf) 
were treated with different reagents and lysed with 1% 
Triton X-100 (Himedia laboratories Pvt Ltd, Mumbai, India) 
in the presence of protease inhibitors. Lysate (20 µg) was 
added to each well in 96-well plates precoated with   histone. 
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Figure 1 Characterization of silver nanoparticles. (A) Silver nanoparticles showing spherical, monodispersed particles (scale bar, 50 nm). The inset shows one single particle 
of silver (scale bar, 5 nm). (B) Particle size distribution showing preponderance of particles in the size range of 10–15 nm. (C) Electron diffraction pattern of nanoparticles 
showing various crystallographic planes. (D) Optical spectra of silver before (1) and after reduction (2). The inset shows the corresponding change in color.
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PARP activity was determined from the   incorporation 
of biotinylated poly(adenosine diphosphate-ribose) onto 
immobilized histone, which was measured by the addition of 
steptavidin-conjugated horseradish peroxidise and a suitable 
chromogenic substrate to the incubation mixture. A standard 
curve for PARP enzymatic activity (A450 versus PARP units) 
was initially generated using 0.01, 0.05, 0.1, 0.5, and 1 unit 
of enzyme per well. The absorbance obtained with each test 
sample (microfilarial lysate) was extrapolated on the standard 
curve to obtain the corresponding PARP activity. The control 
sample (microfilaria without any pretreatment) provided 
100% activity reference point. The percentage inhibition 
in enzymatic activity in other test samples (lysates treated 
with different reagents) was accordingly calculated. The 
experiment was carried out in triplicate and the percentage 
inhibition was averaged over the experiments.
Ethidium bromide/Acridine orange  
(EB/AO) staining for the detection  
of apoptosis
Dual staining with EB/AO was carried out as described 
  elsewhere.22 The dye mix consisted of 100 µg/mL EB and 
100 µg/mL AO in phosphate-buffered saline.   Microfilariae 
(control as well as treated with different reagents for 48 hours) 
were washed and resuspended in 25 µL cold phosphate-buffered 
saline, followed by the addition of 5 µL EB/AO dye mix. 
Stained microfilariae were viewed under an epifluorescence 
microscope (Nikon) with the excitation filter set at 480/30 nm 
and the barrier filter at 535/40 nm. Tests were carried out in trip-
licate, counting a minimum of 10 Mf in each observation.
Electron microscopy
Mf were treated with staurosporine, AgNPs, or AuNPs 
for 48 hours. Samples were fixed in Karnovsky fixative 
(pH 7.2) for 2 hours at 4°C followed by postfixation in 
osmium   tetroxide (1%) and then dehydrated in ascending 
concentrations of acetone. For scanning electron microscopy, 
dehydrated samples were critical point dried, mounted on an 
aluminum stub with adhesive tape, and sputter-coated with 
  colloidal gold. Specimens were viewed under a Leo 435VP 
  scanning electron microscope (LEO Electron Microscopy 
Ltd, Cambridge, UK) at an operating voltage of 15 kV . For 
transmission electron microscopy, blocks were prepared as 
previously described.23 Ultrathin sections (60–70 nm thick) 
were prepared with an ultramicrotome (Leica EM UC6; 
Leica Microsystems GmbH, Wetzlar, Germany). Sections 
were contrasted with uranyl acetate and alkaline lead   citrate. 
Specimens were mounted on formvar-coated grids and 
viewed under a FEI Morgagni™ 268(D) (FEI, Hillsboro, 
OR) digital transmission electron microscope at 120 kV using 
image analysis software from Soft Imaging System GmbH 
(Muenster, Germany). The final magnifications were derived 
from the photo micrographs and the scale bars determined.
Results and discussion
AgNPs were synthesized through the aqueous chemical 
  precipitation method, as described earlier.11,19,20 Nanoparticles 
were spherical in shape, 10–15 nm in diameter (Figure 1A), 
and monodispersed with a narrow particle size distribution 
(Figure 1B). The selected area electron diffraction pattern 
from these particles matched the crystallographic planes 
of the face-centered cubic AgNPs (Figure 1C). Ultraviolet–
visible absorption spectra showed the reduction of silver ions 
into the AgNPs under ambient conditions (Figure 1D). The 
inset shows the color changes before and after the process 
of reduction. The silver nitrate solution exhibited maximum 
absorbance at 300 nm, which gradually underwent red shift 
with the appearance of a sharp peak at 410 nm, which can 
be attributed to a narrow size distribution of the particles 
formed in the solution.
The microfilariae remained viable and motile in RPMI 
media, as expected. The effect of AgNPs (10–15 nm) upon 
Mf motility was evaluated over a wide concentration range. 
Remarkably, at 4.6 µM, the AgNPs evoked motility loss in 
50% of Mf population, whereas at 50.6 µM, the AgNPs ren-
dered the entire Mf population immotile (Table 1). The AuNPs 
(10–15 nm) failed to produce any significant antifilarial effect at 
the identical concentrations. However, staurosporine (0.5 µM) 
as a positive control induced complete loss in Mf motility. 
Table 1 Brugia malayi microfilariae were incubated with silver 
nanoparticles at varying concentrations
Concentration  
of AgNPs (μM)
Percentage loss  
in Mf motility
  4.6 50.0 ± 2.63
  9.2 76.5 ± 0.88
13.8    85 ± 1.17
18.4    89 ± 0
23    92 ± 0.58
27.6    94 ± 0.58
32.2    98 ± 0
36.8 97.5 ± 0.29
41.4    99 ± 0
50.6  100 ± 0
Notes: The percentage loss in the motility of microfilarial forms was recorded 
after 48 hours. Each experiment was carried out in triplicate and the results were 
presented as mean ± standard error of the mean.
Abbreviations: AgNPs, silver nanoparticles; Mf, microfilarial forms.
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When evaluated for the extent of cytotoxicity by trypan blue 
exclusion test, AgNPs at 101.2 µM elicited 50% lethality.
The inhibition of PARP activity is a valid measure for the 
assessment of cellular apoptosis.24 During apoptosis, PARP 
is cleaved by caspase 3 with an ensuing reduction in PARP 
enzyme activity, which thus prevents apoptotic cells from 
repairing their own DNA.25 PARP activity in Mf exposed 
to nanosilver (50 µM), nanogold (50 µM), or staurosporine 
(0.5 µM) was then studied. Both AgNPs and staurosporine 
induced nearly 70% attenuation in PARP enzymatic activity, 
whereas only 25% loss in activity was observed in the pres-
ence of AuNPs (Table 2), thus consistent with the significant 
microfilaricidal effect of nanoscale silver.
The interaction between microfilariae and nanosilver was 
further investigated with EB and AO differential staining.22 
AO permeates into healthy live cells to stain the nuclear mate-
rial green, whereas cellular access of EB is restricted, unless 
there is membrane damage. Mf treated with AgNPs (50 µM) 
and staurosporine (0.5 µM) were stained orange-yellow with 
EB (Figure 2B and C), which reflected loss in surface mem-
brane integrity. This contrasted with the profile of control 
parasites as well as that of Mf exposed to AuNPs (50 µM), 
which were stained green with AO (Figure 2A and D).
Nanosilver-induced ultrastructural changes in microfilariae 
were subsequently investigated by electron microscopy. 
Scanning electron microscopy images reflected marked loss 
in microfilarial sheath in parasites treated either with stauro-
sporine (0.5 µM) or AgNPs (50 µM), whereas RPMI-treated 
control microfilariae or parasites exposed to AuNPs (50 µM) 
exhibited clear undamaged translucent sheaths (Figure 3).
Transmission electron microscopy images of ultrathin 
sections of microfilariae, pretreated either with staurosporine 
or AgNPs, revealed multiple large, round vacuoles inside 
cells (Figure 4). On the contrary, vacuoles were scanty in 
parasites treated with AuNPs and absent in RPMI-treated con-
trol   parasites, which possessed thick homogeneous   cuticles 
and intact cell organelles without vacuoles. The presence of 
  vacuoles in ultrastructural sections of staurosporine-treated 
as well as AgNP-treated microfilariae further confirmed the 
apoptotic rationale in the pharmacodynamics of AgNPs. It may 
be noted that, conventional mechanisms for the study of apop-
tosis such as terminal deoxynucleotidyl   transferase-mediated 
deoxyuridine triphosphate nick end labeling assay and DNA 
fragmentation are not technically viable in a parasite   model.17 
Taken together, the above findings were consistent with 
apoptotic changes induced in microfilariae in the presence of 
nanosilver similar to that elicited by staurosporine. Nanogold 
of comparable size and concentration, on the other hand, had 
no adverse effect on parasites.
Figure 2 Ethidium bromide/acridine orange differential staining of microfilarial forms 
for the detection of apoptosis. Untreated (A) and gold nanoparticles preincubated 
(D) nuclei showed green staining due to acridine orange permeation, while organisms 
treated with silver nanoparticles (B) and staurosporine (C) appeared orange-yellow 
due to ethidium bromide, suggesting loss of integrity of surface membrane of the 
parasite shown.
Note: Data are representative of three different experiments.
Table 2 Percentage inhibition in poly(adenosine   diphosphate-
ribose)  polymerase  activity  in  the  microfilariae  treated  with 
different reagents as indicated compared with control (Roswell 
Park Memorial Institute medium only)
Reagents Percentage inhibition   
in PARP activity  
(mean ± SEM)
AgNPs (50 µM) 71.62 ± 3.23
AuNPs (50 µM) 25.88 ± 1.09
Staurosporine (0.5 µM) 67.82 ± 4.13
Abbreviations:  AgNPs,  silver  nanoparticles;  AuNPs,  gold  nanoparticles;  PARP, 
poly(adenosine diphosphate-ribose) polymerase; SEM, standard error of the mean.
Figure  3  Scanning  electron  micrographs  of  (A)  untreated  control  parasite 
in  Roswell  Park  Memorial  Institute  medium;  (B)  microfilariae  treated  with 
staurosporine (0.5 µM); (C) microfilariae treated with silver nanoparticles (50 µM), 
and (D) microfilariae treated with gold nanoparticles (50 µM).
Note: Data are representative of three different experiments.
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DEC has been shown to induce apoptosis in the microfi-
lariae of W. bancrofti,17 though the drug is not known to be 
filaricidal in vitro.26 Thus, apoptosis induction in vitro by 
DEC may not be sufficient to kill the parasite, which could 
couple with the innate inflammatory response of the host to 
elicit effective antifilarial activity in vivo. In support of this, 
the cuticles of adult and microfilarial B. malayi were found 
to be resistant to hydrogen peroxide, a strong oxidant as 
well as apoptosis-inducing agent, which is attributable to the 
presence of α-tocopherol in the lipid fraction of the parasite 
surface.27 Interestingly, DEC in combination with hydrogen 
peroxide was found to have marked synergism against filarial 
parasites.28 The above facts underpinned the relative inef-
fectiveness of DEC as the sole filaricidal agent and prompts 
researchers to strategize combinations with apoptosis induc-
ers as a novel lead for antifilarial therapeutics.
In an earlier report, the enhanced antibacterial potency 
of AgNPs was analyzed.11 Commendable efforts have been 
made to explore the underlying molecular mechanism of the 
antimicrobial activity of silver.29 Dissolved silver ions could 
be responsible for some of the biological actions of AgNPs 
against microorganisms30,31 through their interaction with and 
inhibition of the thiol groups of vital enzymes.29,32 It has been 
recently demonstrated that the rate of ionization of silver from 
nanoparticles is significantly affected by the presence of salts 
and biomolecules in the suspension medium.33 Biological 
media contain large numbers of interfering molecules in 
abundance, which can thus influence the release of silver 
ions. It is unlikely that silver ions will rise to a significant 
level under the present experimental conditions, as reducing 
agents like glucose present in RPMI would keep these ions 
in the reduced state, and high concentration of chloride and 
phosphate ions in the medium would generate insoluble salts 
of silver (eg, silver chloride and silver phosphate). Besides 
this, the presence of citric acid during the process of AgNP 
synthesis would result in surface coating of the nanoparticles 
with citrate ions which would further limit the release 
of silver ions, as reported recently.33 Thus, the observed 
antimicrofilarial activity reported in this study is most likely 
attributable to AgNPs per se and not to silver ions.
Conclusion
The main embargo on the current drug DEC is its empirical 
use without rationale. DEC-based mass drug administra-
tion policy demands longer durations of therapy, which 
may lack patient compliance and thus lead to frequent 
failure.34 AgNPs, on the other hand, are capable of inducing 
apoptosis in mammalian cells.14–16 The effective microfila-
ricidal   activity of AgNPs at relatively low concentration as 
reported in this study, with evidence of apoptotic induction 
in microfilariae, can project nanosilver as a potential drug 
adjuvant against lymphatic filariasis. Unlike DEC, which 
is effective against microfilariae only in vivo and not in 
vitro,35 nanosilver promises greater therapeutic effective-
ness. Remarkably, a recent report has demonstrated the 
therapeutic potential of AgNPs against leishmaniasis, 
another parasitic disease caused by Leishmania tropica.36 
However, the antiparasitic mechanism elucidated in this 
study was oxidative attack by AgNPs, which was further 
potentiated by the concomitant ultraviolet exposure. This 
mechanism is hardly of therapeutic relevance in the pres-
ent study as filarial parasites are known to be endowed 
with robust antioxidant defenses. On the contrary, based 
on evidence presented in the present study, apoptosis 
is proposed as the mechanistic basis of the antifilarial 
activity of nanosilver. Interestingly, there is a subtle link 
reported between oxidative stress and apoptosis induction.37 
Filarial parasites are lymphatic system-specific organ-
isms. Given the wide distribution attainable by AgNPs in 
tissues including lymphatics,38 administered nanosilver is 
expected to achieve a desired local antifilarial therapeutic 
concentration in the infected population. Nanosilver may 
act synergistically with DEC and thus may be effective 
either individually or as an adjunct (at lower individual 
doses) to this standard drug, after critical evaluation of 
safety parameters. Although there have been concerns 
regarding the toxicity of nanoparticles in general,39 and 
Figure 4 Transmission electron micrographs through sections of (A) untreated 
control parasite in Roswell Park Memorial Institute medium; (B) microfilariae treated 
with staurosporine (0.5 µM); (C) microfilariae treated with silver nanoparticles 
(50 µM); and (D) microfilariae treated with gold nanoparticles (50 µM).
Notes: Arrows point to the vacuoles; data are representative of three different 
experiments.
Abbreviation: V, vacuoles.
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silver in particular,16,40 nanosilver might be considered to   
have a safe therapeutic window. The 50% lethal dose of 
nanosilver (100 µM), which is double the complete inhibi-
tory concentration value (50 µM) as reported in the present 
study, supports this contention. The report on Leishmania 
parasites has demonstrated the synergism between nanosil-
ver and ultraviolet exposure in their antiparasitic effect.36 
This study did not find any serious toxicity concern with 
silver. Thus, it can be inferred that AgNPs may be used as an 
adjuvant to DEC to potentiate synergistic apoptotic impact, 
so that the dose requirement of nanosilver may be further 
scaled down. To summarize, the present report provides 
the first ever conclusive proof in support of apoptosis as a 
novel stratagem in antifilarial drug designing and nanosilver 
as a valid lead in the research on antifilarial therapeutics.
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